Clinical Trial Update: Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining dose reduction and acute glycemic complications in people with type 2 diabetes who fast during Ramadan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Jordan | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED